TVRD Earnings Tvardi Therapeutics, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–39 of 39
| Q2 2026 | 2026-06-30 | -0.69 | 2026-08-14 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.73 | 2026-05-08 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | 2.05 | 2026-03-31 | 10-K |
| FY 2025 | 2025-12-31 | -3.26 | 2026-03-31 | 10-K |
| Q3 2025 | 2025-09-30 | -0.59 | 2025-11-13 | 10-Q |
| Q2 2025 | 2025-06-30 | -1.00 | 2025-08-14 | 10-Q |
| Q1 2025 | 2025-03-31 | -3.72 | 2025-05-13 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | 13.67 | 2025-03-11 | 10-K |
| FY 2024 | 2024-12-31 | -11.42 | 2025-03-11 | 10-K |
| Q3 2024 | 2024-09-30 | -2.14 | 2024-11-14 | 10-Q |
| Q2 2024 | 2024-06-30 | -2.71 | 2024-08-14 | 10-Q |
| Q1 2024 | 2024-03-31 | -20.24 | 2024-05-13 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | -13.95 | 2024-03-06 | 10-K |
| FY 2023 | 2023-12-31 | -19.70 | 2024-03-06 | 10-K |
| Q3 2023 | 2023-09-30 | -4.68 | 2023-11-13 | 10-Q |
| Q2 2023 | 2023-06-30 | -0.58 | 2023-08-07 | 10-Q |
| Q1 2023 | 2023-03-31 | -0.49 | 2023-05-15 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | -9.87 | 2023-03-06 | 10-K |
| FY 2022 | 2022-12-31 | -14.34 | 2023-03-06 | 10-K |
| Q3 2022 | 2022-09-30 | -3.87 | 2022-11-07 | 10-Q |
| Q2 2022 | 2022-06-30 | -0.08 | 2022-08-08 | 10-Q |
| Q1 2022 | 2022-03-31 | -0.52 | 2022-05-09 | 10-Q |
| Q4 2021 (derived) | 2021-12-31 | -9.52 | 2022-03-01 | 10-K |
| FY 2021 | 2021-12-31 | -15.66 | 2022-03-01 | 10-K |
| Q3 2021 | 2021-09-30 | -0.18 | — | — |
| Q2 2021 | 2021-06-30 | -5.49 | — | — |
| Q1 2021 | 2021-03-31 | -0.47 | — | — |
| Q4 2020 | 2020-12-31 | 14.31 | 2021-02-25 | 10-K |
| FY 2020 | 2020-12-31 | 1.62 | 2021-02-25 | 10-K |
| Q3 2020 | 2020-09-30 | -3.15 | — | — |
| Q2 2020 | 2020-06-30 | -4.86 | — | — |
| Q1 2020 | 2020-03-31 | -5.58 | — | — |
| FY 2019 | 2019-12-31 | -22.41 | — | — |
| FY 2018 | 2018-12-31 | -18.54 | — | — |
| Q2 2014 | 2014-06-30 | -1.44 | 2014-08-07 | 10-Q |
| Q4 2014 | 2013-12-31 | -4.41 | 2015-03-27 | 10-K |
| Q3 2014 | 2013-09-30 | -9.63 | — | — |
| Q2 2014 | 2013-06-30 | 2.97 | — | — |
| Q1 2014 | 2013-03-31 | -4.32 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.